Leidos (NYSE:LDOS) Posts Earnings Results, Beats Estimates By $0.59 EPS

Leidos (NYSE:LDOS) posted its quarterly earnings results on Tuesday. The aerospace company reported $2.29 EPS for the quarter, topping the consensus estimate of $1.70 by $0.59, RTT News reports. The company had revenue of $3.98 billion for the quarter, compared to the consensus estimate of $3.82 billion. Leidos had a net margin of 1.29% and a return on equity of 22.92%. The firm’s revenue was up 7.5% compared to the same quarter last year. During the same quarter last year, the firm posted $1.47 EPS. Leidos updated its FY 2024 guidance to 8.400-8.800 EPS and its FY24 guidance to $8.40-8.80 EPS.

Leidos Price Performance

Shares of NYSE:LDOS opened at $131.62 on Tuesday. The company has a current ratio of 1.34, a quick ratio of 1.24 and a debt-to-equity ratio of 1.10. Leidos has a twelve month low of $76.58 and a twelve month high of $132.34. The company’s 50 day moving average is $127.74 and its 200 day moving average is $114.22. The company has a market cap of $17.79 billion, a PE ratio of 92.69, a price-to-earnings-growth ratio of 1.80 and a beta of 0.70.

Leidos Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, May 28th. Investors of record on Tuesday, May 14th will be issued a dividend of $0.38 per share. This represents a $1.52 dividend on an annualized basis and a dividend yield of 1.15%. The ex-dividend date of this dividend is Friday, June 14th. Leidos’s dividend payout ratio (DPR) is 107.04%.

Insider Buying and Selling at Leidos

In other Leidos news, Director Gary Stephen May sold 2,745 shares of the company’s stock in a transaction on Wednesday, February 21st. The shares were sold at an average price of $124.49, for a total value of $341,725.05. Following the sale, the director now directly owns 11,352 shares of the company’s stock, valued at $1,413,210.48. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. In related news, Director Gary Stephen May sold 2,745 shares of Leidos stock in a transaction that occurred on Wednesday, February 21st. The stock was sold at an average price of $124.49, for a total transaction of $341,725.05. Following the completion of the transaction, the director now directly owns 11,352 shares in the company, valued at $1,413,210.48. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director David G. Fubini sold 7,874 shares of the business’s stock in a transaction that occurred on Wednesday, March 13th. The shares were sold at an average price of $127.89, for a total value of $1,007,005.86. Following the completion of the transaction, the director now directly owns 14,696 shares of the company’s stock, valued at $1,879,471.44. The disclosure for this sale can be found here. Company insiders own 0.96% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts have recently commented on the stock. Robert W. Baird raised their target price on shares of Leidos from $133.00 to $145.00 and gave the stock an “outperform” rating in a research report on Wednesday, February 14th. Barclays raised Leidos from an “equal weight” rating to an “overweight” rating in a research report on Friday, January 5th. Argus increased their price target on Leidos from $120.00 to $145.00 and gave the stock a “buy” rating in a research report on Wednesday, March 20th. Truist Financial lifted their price objective on Leidos from $135.00 to $150.00 and gave the company a “buy” rating in a report on Tuesday, April 9th. Finally, StockNews.com cut shares of Leidos from a “strong-buy” rating to a “buy” rating in a report on Friday. Two research analysts have rated the stock with a hold rating and eleven have given a buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $132.42.

About Leidos

Leidos Holdings, Inc, together with its subsidiaries, provides services and solutions in the defense, intelligence, civil, and health markets in the United States and internationally. The company operates through Defense Solutions, Civil, and Health segments. The Defense Solutions segment offers national security solutions and systems for air, land, sea, space, and cyberspace for the U.S.